Karin Rosen
Chief Tech/Sci/R&D Officer at HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Karin Rosen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/11/2020 | - |
| DIAMYD MEDICAL AB | Director/Board Member | 09/03/2023 | - |
Career history of Karin Rosen
Former positions of Karin Rosen
| Companies | Position | Start | End |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | 31/10/2018 | 31/10/2020 |
Training of Karin Rosen
| University of Lund | Doctorate Degree |
Statistics
International
| Sweden | 3 |
| Ireland | 2 |
| United Kingdom | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| Private companies | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Karin Rosen
- Experience
